UBS Group »

Zhengye Biotechnology Hldg L shares owned by UBS Group

Quarter-by-quarter ownership of Zhengye Biotechnology Hldg L (ZYBT) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Zhengye Biotechnology Hldg L

Tip: Access up to 7 years of quarterly data

All positions including Zhengye Biotechnology Hldg L held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zhengye Biotechnology Hldg L by UBS Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $11k 4.3k 2.62
2025-06-30 $922k 155k 5.97
2025-03-31 $6.9k 1.3k 5.38

More positions owned by UBS Group

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Ubs Group SHS (UBS)
Tesla Motors (TSLA)
Ishares Tr Russell 2000 Etf (IWM)
Visa Com Cl A (V)

View all positions for UBS Group

Top funds holding Zhengye Biotechnology Hldg L

Invesco
XTX Topco
Geode Capital Management
Winton Capital
Millennium Management
Citadel Advisors
Tower Research Capital
UBS Group
Morgan Stanley
Caitong International Asset Management

View all funds holding Zhengye Biotechnology Hldg L